BioMarin Pharmaceuticals
BMRN
BMRN
306 hedge funds and large institutions have $9.95B invested in BioMarin Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 101 increasing their positions, 115 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
12% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 115
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Holders
306
Holding in Top 10
7
Calls
$94.9M
Puts
$58.2M
Top Buyers
| 1 | +$101M | |
| 2 | +$81.5M | |
| 3 | +$70.5M | |
| 4 |
Millennium Management
New York
|
+$62.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$51.7M |
Top Sellers
| 1 | -$274M | |
| 2 | -$40.9M | |
| 3 | -$40.1M | |
| 4 |
D.E. Shaw & Co
New York
|
-$39.8M |
| 5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$34.4M |